
				Moderators: R. Ferraresi, A. Sauguet, E. Ducasse
				State of the art of BTK-CLI treatment
			Animator: K. Deloose
			Is it still a question (for large access)? S. Haulon
			Animator: B. Mees
			Moderators: L. Canaud, N. Mangialardi, F. Pecoraro
| Real world TAA Case Extravaganza 14.00 - How would you treat it? Challenging scenarios that stump the experts, L. Canaud Points of interest 14.08 - Real incidences of endoleaks after TEVAR, R. McWilliams | 
			Animator: K. Deloose
			Moderators: E. Jean-Baptiste, B. Mees, N. Mosquera
			Debate
			14.20 - Are we pushing too far the frontiers of EVAR? E. Steinmetz
			14.28 - There are no limits using EVAR for AAA! F. Noya
			
			Hot Topics
			14.36 - Best practice in fEVAR in 2016, B. Mees
			14.44 - EVAS and chEVAS will replace EVAR and chEVAR, F. Torella
			14.52 - Chimps and regular devices are still a valuable option, F. Pecoraro
			15.00 - Ultra low profile device: behind the boundaries! X. Bérard
			
			Tips and Tricks
			15.08 - Management of the hypogastric artery during EVAR, F. Torella
			15.16 - Perfect proximal anchorage. Does it solve all the problems? J-P. de Vries
			15.24 - Management of challenging iliac accesses and leg thrombosis prevention, A Mansilha
			15.32 - The usage of covered balloon expandable stent in Ch-EVAR/S procedures, J-P. de Vries
			15.40 - Physician-made versus regular fenestration, is there a difference? E. Ducasse
			
			Real World AAA Case Extravaganza
			15.56 - How would you treat it? Challenging scenarios that stump the experts, B. Mees, T. Larzon
			
			Points of Interest
			16.12 - How to deal with type 1 endoleaks? N. Cheshire
			16.20 - Diagnosis and management of type 3b endoleak, R. McWilliams
			16.28 - Sorry to curb the enthusiasm, but how to treat the infected endografts? X. Berard
			Moderators: S. Chastanet, P. Pittaluga
			
			17.30 Would you treat it? Challenging scenarios that stump the expert. B.Mees
			17.30 What might bring a new wave length for endovenous laser? L. Kabnick
			17.40 Should we really treat varicose tributaries? S. Onida
			18.00 Hemodynamics of development of the varicose disease: do we really have a new knowledge? S. Onida
			18.10 Endovenous treatment of the short saphenous vein: as good as for the great saphenous vein? P. Nicolini
			18.20 Endovascular treatment of extended iliac vein occlusion: what are the limits? A. Davies
			18.30 What will be the treatment of varicose veins in the future? R. Milleret
			18.40 Management strategies for patients with varicose veins (C2-C6): results of a worldwide survey, A. Davies
				Animator: P. Schneider
				Moderator: M. Amor, I. Van Herzeele
Animator: R. Milleret, P. Nicolini
			Moderators: Y. Gouëffic, K. Deloose
			The usage of DET in my practice, J. Sobocinski, G. Goyault
			Endovascular repair for long femoropopliteal lesions
			Animator: K. Deloose
			Moderators: Y. Gouëffic, J. Lemoine
			Animators: E. Steinmetz
			Moderator: L. Maene, G. Torsello
			14.50 State of art, P. Schneider
			15.00 Missing data, F. Airoldi
			15.20 Real life, Y. Gouëffic
			Debate
			15.30 - For 4F devices with 0.018, O. Regnard
			15.40 - For 5F devices with 0.035, F. Airoldi
			16.10 - Outpatients management is profitable, Y. Gouëffi
0Rejoindre la discussion
MEET Congress 2015 - Discussion